Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Theratechnologies Q4 EPS $(0.08) May Not Be Comparable To $(0.24) Estimate, Sales $23.45M Beat $23.36M Estimate

Author: Benzinga Newsdesk | February 21, 2024 08:33am
Theratechnologies (NASDAQ:THTX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.24) by 66.67 percent. This is a 11.11 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $23.45 million which beat the analyst consensus estimate of $23.36 million by 0.39 percent. This is a 9.48 percent increase over sales of $21.42 million the same period last year.

Posted In: THTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist